Clinical trial
Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic…
NCT00439712 · Institut für Atemwegsforschung GmbH, Industry · Completed
Key facts
| NCT number | NCT00439712 |
|---|---|
| Title | Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis |
| Official title | Efficacy of Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Rhinitis |
| Lead sponsor | Institut für Atemwegsforschung GmbH, Industry |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Perennial Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Levocetirizine, Placebo |
| Enrollment | 60 |
| Start date | Feb 1, 2007 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Feb 26, 2007 |
| Last update posted | Jan 15, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: